Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
General Primary Care
•
General Psychiatry
Do you recommend tapering patients with long-term benzodiazepine use for anxiety who are stable and functional, and assuming no side effects or concerns for misuse?
Related Questions
How long do you generally continue anti-depressants for mild-to-moderate depression who have achieved remission?
Do you recommend restarting GLP-1RA after bariatric surgery if they tolerated it before the surgery?
In the absence of clear guidelines, when would be a reasonable threshold to refer patients with resistant hypertension for renal denervation?
What is your medication of choice when considering outpatient alcohol withdrawal management (diazepam vs chlordiazepoxide vs lorazepam)?
How do you evaluate the etiology of hyponatremia in a patient with ESRD and baseline oliguria/anuria?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
What should the LDL target be in patients with prediabetes and high lipoprotein (a) with family history of coronary artery disease?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
How would you treat a patient with osteoarthritis of just one joint of the hand?
Do you recommend routinely monitoring pancreatic markers such as amylase and lipase while receiving GLP1 R agonist or dual agonist therapies to determine their risk of pancreatitis?
